Ahmad, S.; Jayamanne, D.; Bergamin, S.; Lawless, A.; Guminski, A.; Lee, A.; Yuile, A.; Wheeler, H.; Eade, T.; Back, M.;
et al. Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions. Cancers 2025, 17, 2667.
https://doi.org/10.3390/cancers17162667
AMA Style
Ahmad S, Jayamanne D, Bergamin S, Lawless A, Guminski A, Lee A, Yuile A, Wheeler H, Eade T, Back M,
et al. Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions. Cancers. 2025; 17(16):2667.
https://doi.org/10.3390/cancers17162667
Chicago/Turabian Style
Ahmad, Saad, Dasantha Jayamanne, Sarah Bergamin, Anna Lawless, Alexander Guminski, Adrian Lee, Alexander Yuile, Helen Wheeler, Thomas Eade, Michael Back,
and et al. 2025. "Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions" Cancers 17, no. 16: 2667.
https://doi.org/10.3390/cancers17162667
APA Style
Ahmad, S., Jayamanne, D., Bergamin, S., Lawless, A., Guminski, A., Lee, A., Yuile, A., Wheeler, H., Eade, T., Back, M., Molloy, M., & Oh, B.
(2025). Oral Microbiome as a Biomarker and Therapeutic Target in Head and Neck Cancer: Current Insights and Future Directions. Cancers, 17(16), 2667.
https://doi.org/10.3390/cancers17162667
